Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC22A16 | Q86VW1 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 2/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | BBOX1 | O75936 | 2/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Glycerin SCHEMBL5667635 | 0.89 | SMN1; SMN2 (0.36) | SLC22A16LMNASMN1; SMN2MAPTALDH1A1 | |
| SCHEMBL14742785 | 0.89 | BBOX1 (0.41) | SLC22A16LMNASMN1; SMN2MAPTBBOX1 | |
| SCHEMBL8010 | 0.89 | BBOX1 (0.41) | SLC22A16LMNASMN1; SMN2MAPTBBOX1 | |
| Glycerin SCHEMBL464785 | 0.88 | SLC22A16 (0.38) | SLC22A16LMNASMN1; SMN2MAPTALDH1A1 | |
| Hydrochloric Acid SCHEMBL434365 | 0.87 | MAPT (0.43) | SLC22A16LMNASMN1; SMN2MAPTBBOX1 | |
| Water SCHEMBL17373732 | 0.87 | BBOX1 (0.39) | SLC22A16LMNASMN1; SMN2MAPTBBOX1 | |
| Bromide SCHEMBL8416789 | 0.87 | BBOX1 (0.39) | SLC22A16LMNASMN1; SMN2MAPTBBOX1 | |
| Hydrochloric Acid SCHEMBL2355625 | 0.85 | MAPT (0.41) | SLC22A16LMNASMN1; SMN2MAPTBBOX1 | |
| Hydroxyamine SCHEMBL8584616 | 0.85 | BBOX1 (0.43) | SLC22A16LMNAMAPTBBOX1 | |
| Hydrochloric Acid SCHEMBL933391 | 0.85 | MAPT (0.41) | SLC22A16LMNASMN1; SMN2MAPTBBOX1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 50 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4110328-A1 | INTERVENTION STRATEGY FOR PREVENTION OR TREATMENT OF DIABETES MELLITUS, AUTOIMMUNE DISEASE, INFLAMMATORY DISEASE OR CARDIOVASCULAR DISEASE | Academisch Medisch Centrum (NL) | 2023-01-04 | — | — | EP | claimed |
| CN-111053757-A | Lipid nanoparticles targeting hepatic stellate cells, preparation method and application thereof | 吉优诺（上海）基因科技有限公司 | 2020-04-24 | — | — | CN | claimed |
| CN-105837652-A | Betulinic acid-phosphatide composites, and preparing method and uses thereof | 哈尔滨理工大学 | 2016-08-10 | — | — | CN | claimed |
| CN-105784980-A | Glycerophosphoryl choline degradation or detection enzymologic method, product and application thereof | 丰益(上海)生物技术研发中心有限公司 | 2016-07-20 | — | — | CN | claimed |
| EP-4339616-A1 | BIOMARKER COMPOSITION CONTAINING ACYL CARNITINE METABOLITE FOR DIAGNOSIS OF ORAL CANCER | National Cancer Center (KR) | 2024-03-20 | — | — | EP | disclosed |
| US-20230181531-A1 | INTERVENTION STRATEGY FOR PREVENTION OR TREATMENT OF DIABETES MELLITUS, AUTOIMMUNE DISEASE, INFLAMMATORY DISEASE OR CARDIOVASCULAR DISEASE | Stichting Amsterdam UMC (NL) | 2023-06-15 | — | — | US | disclosed |
| US-20230181531-A1 | INTERVENTION STRATEGY FOR PREVENTION OR TREATMENT OF DIABETES MELLITUS, AUTOIMMUNE DISEASE, INFLAMMATORY DISEASE OR CARDIOVASCULAR DISEASE | Stichting Amsterdam UMC (NL) | 2023-06-15 | — | — | US | disclosed |
| CN-115754047-A | Method for detecting residual quantity of glycerin and glycerin chloride in glycerophosphorylcholine | 中山百灵生物技术股份有限公司 | 2023-03-07 | — | — | CN | disclosed |
| EP-4110328-A1 | INTERVENTION STRATEGY FOR PREVENTION OR TREATMENT OF DIABETES MELLITUS, AUTOIMMUNE DISEASE, INFLAMMATORY DISEASE OR CARDIOVASCULAR DISEASE | Academisch Medisch Centrum (NL) | 2023-01-04 | — | — | EP | disclosed |
| EP-4110328-A1 | INTERVENTION STRATEGY FOR PREVENTION OR TREATMENT OF DIABETES MELLITUS, AUTOIMMUNE DISEASE, INFLAMMATORY DISEASE OR CARDIOVASCULAR DISEASE | Academisch Medisch Centrum (NL) | 2023-01-04 | — | — | EP | disclosed |
| US-20210244784-A1 | COMPOSITION, AND METHOD OF USING THE COMPOSITION, EFFECTIVE FOR MINIMIZING THE HARMFUL EFFECTS ASSOCIATE WITH INDIVIDUALS SUFFERING FROM ALCOHOL INTOXICATION | GDB PATENT HOLDINGS, LLC (US) | 2021-08-12 | — | — | US | disclosed |
| CN-105784980-B | Degradation or Enzymology method, product and its application of detection choline glycerophosphatide | 丰益(上海)生物技术研发中心有限公司 | 2019-10-18 | — | — | CN | disclosed |
| US-20070166382-A1 | Bioresponsive polymer system for delivery of microbicides | UNIVERSITY OF UTAH RESEARCH FOUNDATION | 2007-07-19 | — | — | US | disclosed |
| EP-1737500-A1 | BIORESPONSIVE POLYMER SYSTEM FOR DELIVERY OF MICROBICIDES | The University of Utah Research Foundation (US) | 2007-01-03 | — | — | EP | disclosed |
| WO-2005097210-A1 | BIORESPONSIVE POLYMER SYSTEM FOR DELIVERY OF MICROBICIDES | THE UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) | 2005-10-20 | — | — | WO | disclosed |
| EP-0935139-B1 | IMMUNOHISTOCHEMICAL STAINING COMPOSITION | DAIICHI PURE CHEMICALS CO LTD (JP) | 2004-11-17 | — | — | EP | disclosed |
| EP-1364224-A1 | MAGNETIC RESONANCE SPECTROSCOPY TO IDENTIFY AND CLASSIFY MICROORGANISMS | NATIONAL RESEARCH COUNCIL OF CANADA (CA) | 2003-11-26 | — | — | EP | disclosed |
| WO-2002067005-A1 | MAGNETIC RESONANCE SPECTROSCOPY TO IDENTIFY AND CLASSIFY MICROORGANISMS | NATIONAL RESEARCH COUNCIL OF CANADA (CA) | 2002-08-29 | — | — | WO | disclosed |
| US-20020028474-A1 | Composition for immunohistochemical staining | DAIICHI PURE CHEMICAL CO., LTD. (JP) | 2002-03-07 | — | — | US | disclosed |
| EP-0935139-A1 | IMMUNOHISTOCHEMICAL STAINING COMPOSITION | DAIICHI PURE CHEMICALS CO., LTD. (JP) | 1999-08-11 | — | — | EP | disclosed |